Matches in Wikidata for { <http://www.wikidata.org/entity/Q91800714> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q91800714 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q91800714 description "scientific article published on 19 February 2019" @default.
- Q91800714 description "wetenschappelijk artikel" @default.
- Q91800714 description "наукова стаття, опублікована в лютому 2019" @default.
- Q91800714 name "Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf/J mice" @default.
- Q91800714 name "Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf/J mice" @default.
- Q91800714 type Item @default.
- Q91800714 label "Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf/J mice" @default.
- Q91800714 label "Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf/J mice" @default.
- Q91800714 prefLabel "Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf/J mice" @default.
- Q91800714 prefLabel "Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf/J mice" @default.
- Q91800714 P1433 Q91800714-0D750DE0-6DAE-4CE4-B6B0-2E25A22C0A5A @default.
- Q91800714 P1476 Q91800714-E71F35FE-EEB5-4FA9-ABB5-5612EF63EC3B @default.
- Q91800714 P2093 Q91800714-499E04D6-14BD-4EAA-B453-143CD6865A1E @default.
- Q91800714 P2093 Q91800714-4F2D3404-A6FA-47AE-A80F-6B9F7E4930D3 @default.
- Q91800714 P2093 Q91800714-5A2EAFA2-FB03-4333-8FE7-18D12DC6FECF @default.
- Q91800714 P2093 Q91800714-69B69365-0B59-4398-BD52-322FF5C56E73 @default.
- Q91800714 P304 Q91800714-4526BB2B-93A0-408D-9E5D-BF9ED618D586 @default.
- Q91800714 P31 Q91800714-5D9A1F09-AF15-42A0-817B-5A1357042EE3 @default.
- Q91800714 P356 Q91800714-F2E2F038-DBAB-4BE2-B2AE-8E3DCB3608B0 @default.
- Q91800714 P478 Q91800714-F5C6B158-FF74-4C6C-8976-67C8ABD7ECA8 @default.
- Q91800714 P50 Q91800714-1673FDDD-4AB7-4FD5-B935-873D0E5E78DA @default.
- Q91800714 P50 Q91800714-33FF30CB-3E3A-4E8C-969A-50B936B0D153 @default.
- Q91800714 P50 Q91800714-563DE418-ECBB-4529-B40B-15AFB3159BFE @default.
- Q91800714 P50 Q91800714-EACB8550-6CE0-48D5-A098-2AF66DE0D9AC @default.
- Q91800714 P577 Q91800714-810244A0-CFDC-4106-AFD5-F29ECF0F0D5A @default.
- Q91800714 P698 Q91800714-66F79BE1-BCE5-4F51-9944-308895B645C9 @default.
- Q91800714 P356 J.BBR.2019.02.031 @default.
- Q91800714 P698 30790585 @default.
- Q91800714 P1433 Q3619047 @default.
- Q91800714 P1476 "Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf/J mice" @default.
- Q91800714 P2093 "Faleh Alqahtani" @default.
- Q91800714 P2093 "Khalid E Ibrahim" @default.
- Q91800714 P2093 "Mohammed Alqinyah" @default.
- Q91800714 P2093 "Sheikh F Ahmad" @default.
- Q91800714 P304 "213-224" @default.
- Q91800714 P31 Q13442814 @default.
- Q91800714 P356 "10.1016/J.BBR.2019.02.031" @default.
- Q91800714 P478 "364" @default.
- Q91800714 P50 Q114780534 @default.
- Q91800714 P50 Q80378649 @default.
- Q91800714 P50 Q89867677 @default.
- Q91800714 P50 Q90812827 @default.
- Q91800714 P577 "2019-02-19T00:00:00Z" @default.
- Q91800714 P698 "30790585" @default.